Trial intelligence / Profile preview

Lauromacrogol injection vs surgical excision for oral mucocele

ChiCTR2400089462Phase 4Completed

Sponsor
Hospital of Stomatology, Wuhan University.
Start
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of polidocanol in oral mucocele, ranula and Salivary gland mucocele (2 arms), sponsored by Hospital of Stomatology, Wuhan University. Primary endpoint: Diameter of lesion. Started Sep 2024; status: completed.

02

Drugs

polidocanol
03

Conditions

oral mucoceleranulaSalivary gland mucocele

Beyond the preview

Go deeper on ChiCTR2400089462.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400089462.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call